These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30447295)

  • 21. Pulmonary targeting of nanoparticle drug matrices.
    Dandekar P; Venkataraman C; Mehra A
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):343-53. PubMed ID: 20455773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How can we bring high drug doses to the lung?
    Claus S; Weiler C; Schiewe J; Friess W
    Eur J Pharm Biopharm; 2014 Jan; 86(1):1-6. PubMed ID: 24300444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delivery Technologies for Orally Inhaled Products: an Update.
    Moon C; Smyth HDC; Watts AB; Williams RO
    AAPS PharmSciTech; 2019 Feb; 20(3):117. PubMed ID: 30783904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of pulmonary diseases on the fate of inhaled medicines--a review.
    Wang YB; Watts AB; Peters JI; Williams RO
    Int J Pharm; 2014 Jan; 461(1-2):112-28. PubMed ID: 24291124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deposition of non-spherical particles in bifurcating airways.
    Bunchatheeravate P; Curtis JS
    Pharm Dev Technol; 2014 Dec; 19(8):942-51. PubMed ID: 24320756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implications of increased nanoparticle absorption by infant lungs: future prospects.
    Garcia-Contreras L; Ibrahim M
    Ther Deliv; 2013 Apr; 4(4):417-20. PubMed ID: 23557280
    [No Abstract]   [Full Text] [Related]  

  • 27. Validation of radiolabeling of drug formulations for aerosol deposition assessment of orally inhaled products.
    Devadason SG; Chan HK; Haeussermann S; Kietzig C; Kuehl PJ; Newman S; Sommerer K; Taylor G
    J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25 Suppl 1():S6-9. PubMed ID: 23215848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrogels for controlled pulmonary delivery.
    Du J; Du P; Smyth HD
    Ther Deliv; 2013 Oct; 4(10):1293-305. PubMed ID: 24116913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo testing methods for respiratory drug delivery.
    Agu RU; Ugwoke MI
    Expert Opin Drug Deliv; 2011 Jan; 8(1):57-69. PubMed ID: 21174605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors Affecting Drug Exposure after Inhalation.
    Nováková A; Šíma M; Slanař O
    Prague Med Rep; 2022; 123(3):129-139. PubMed ID: 36107443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Raman characterization and chemical imaging of biocolloidal self-assemblies, drug delivery systems, and pulmonary inhalation aerosols: a review.
    Mansour HM; Hickey AJ
    AAPS PharmSciTech; 2007 Nov; 8(4):E99. PubMed ID: 18181559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols.
    Byron PR; Hindle M; Lange CF; Longest PW; McRobbie D; Oldham MJ; Olsson B; Thiel CG; Wachtel H; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S59-69. PubMed ID: 21133801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-use disposable dry powder inhalers for pulmonary drug delivery.
    Friebel C; Steckel H
    Expert Opin Drug Deliv; 2010 Dec; 7(12):1359-72. PubMed ID: 21080859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using MRI to measure aerosol deposition.
    Thompson RB; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):55-62. PubMed ID: 22463490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The development of models for the evaluation of pulmonary drug disposition.
    Liu X; Jin L; Upham JW; Roberts MS
    Expert Opin Drug Metab Toxicol; 2013 Apr; 9(4):487-505. PubMed ID: 23294005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary absorption - estimation of effective pulmonary permeability and tissue retention of ten drugs using an ex vivo rat model and computational analysis.
    Eriksson J; Sjögren E; Thörn H; Rubin K; Bäckman P; Lennernäs H
    Eur J Pharm Biopharm; 2018 Mar; 124():1-12. PubMed ID: 29191716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propellant-driven metered-dose inhalers for pulmonary drug delivery.
    Smyth HD
    Expert Opin Drug Deliv; 2005 Jan; 2(1):53-74. PubMed ID: 16296735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Trans-Nasal Aerosol Delivery Device for Efficient Pulmonary Deposition.
    Zeman KL; Balcazar JR; Fuller F; Donn KH; Boucher RC; Bennett WD; Donaldson SH
    J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):223-229. PubMed ID: 28157412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway.
    Bitonti AJ; Dumont JA
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1106-18. PubMed ID: 16997417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro/in vivo comparisons in pulmonary drug delivery.
    Newman SP; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):77-84. PubMed ID: 18518834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.